Laura Hildebrand

Lehrstuhl für Pharmazeutische Biologie Department of Radiation Oncology

Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and Niraparib (2024) Mentzel J, Hildebrand L, Kuhlmann L, Fietkau R, Distel L Journal article FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1 (2024) Berfelde J, Hildebrand L, Kuhlmann L, Fietkau R, Distel L Journal article Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells (2024) Klieber N, Hildebrand L, Faulhaber EM, Symank JA, Häck N, Härtl A, Fietkau R, Distel L Journal article Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome (2023) Jesse S, Kuhlmann L, Hildebrand L, Magelssen H, Schmaus M, Timmermann B, Andres S, et al. Journal article Non-Professional Phagocytosis Increases in Melanoma Cells and Tissues with Increasing E-Cadherin Expression. (2023) Unseld LH, Hildebrand L, Putz F, Büttner-Herold M, Daniel C, Fietkau R, Distel L Journal article In Vitro Analysis of Superparamagnetic Iron Oxide Nanoparticles Coated with APTES as Possible Radiosensitizers for HNSCC Cells (2023) Emer C, Hildebrand L, Friedrich B, Tietze R, Fietkau R, Distel L Journal article Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable (2023) Bauer M, Hildebrand L, Rosahl MC, Erber R, Schnellhardt S, Büttner-Herold M, Putz F, et al. Journal article Effect of Citrate- and Gold-Stabilized Superparamagnetic Iron Oxide Nanoparticles on Head and Neck Tumor Cell Lines during Combination Therapy with Ionizing Radiation (2022) Schreiber C, Franzen T, Hildebrand L, Stein R, Friedrich B, Tietze R, Fietkau R, Distel L Journal article Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts (2022) Scheper J, Hildebrand L, Faulhaber EM, Deloch L, Gaipl U, Symank JA, Fietkau R, et al. Journal article Wirkung von Flap Endonuclease 1 Inhibitor FEN1-IN-4 in Kombination mit ionisierender Strahlung auf Mammakarzinomzellen (2022) Berfelde J, Hildebrand L, Jost T, Distel L, Fietkau R Conference contribution, Abstract of a poster